Publication:
Resensitization in suspected penicillin allergy.

dc.contributor.authorDoña, Inmaculada
dc.contributor.authorGuidolin, Lucia
dc.contributor.authorBogas, Gádor
dc.contributor.authorOlivieri, Elisa
dc.contributor.authorLabella, Marina
dc.contributor.authorSchiappoli, Michele
dc.contributor.authorSáenz de Santa María, Rocío
dc.contributor.authorDama, Annarita
dc.contributor.authorSalas, María
dc.contributor.authorSenna, Gianenrico
dc.contributor.authorBonadonna, Patrizia
dc.contributor.authorTorres, María José
dc.date.accessioned2023-05-03T13:28:27Z
dc.date.available2023-05-03T13:28:27Z
dc.date.issued2022-09-15
dc.description.abstractThe diagnosis of allergic reactions to penicillins (AR-PEN) is very complex as there is a loss of sensitization over time, which leads to negative skin tests (STs) and specific IgE in serum, and even to tolerance to the drug involved. However, STs may become positive after subsequent exposure to the culprit drug (resensitization), with the risk of inducing potentially severe reactions. The exact rate of resensitization to penicillins is unknown, ranging from 0% to 27.9% in published studies. To analyze the rate of resensitization in patients with suggestive AR-PEN by repeating STs (retest) after an initial evaluation (IE). Patients with suspected AR-PEN were prospectively evaluated between 2017 and 2020. They underwent STs, and a randomized group also underwent a drug provocation test (DPT) with the culprit. Only patients with negative STs and/or DPT were included. All included cases were retested by STs at 2-8 weeks. A total of 545 patients were included: 296 reporting immediate reactions (IRs) and 249 non-immediate reactions (NIRs). Eighty (14.7%) cases had positive results in retest (RT+): 63 (21.3%) IRs and 17 (6.8%) NIRs (p  Due to the high rate of resensitization, retest should be included in the diagnostic algorithm of IRs to penicillins after an initial negative study, especially in anaphylaxis, to avoid potentially severe reactions after subsequent prescriptions of these drugs.
dc.identifier.doi10.1111/all.15508
dc.identifier.essn1398-9995
dc.identifier.pmid36067012
dc.identifier.unpaywallURLhttps://doi.org/10.1111/all.15508
dc.identifier.urihttp://hdl.handle.net/10668/19905
dc.issue.number1
dc.journal.titleAllergy
dc.journal.titleabbreviationAllergy
dc.language.isoen
dc.organizationHospital Universitario Regional de Málaga
dc.organizationCentro Andaluz de Nanomedicina y Biotecnología-BIONAND
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number214-224
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectanaphylaxis
dc.subjectdrug provocation test
dc.subjectpenicillins
dc.subjectresensitization
dc.subjectskin test, specific IgE
dc.subject.meshHumans
dc.subject.meshAnaphylaxis
dc.subject.meshSkin Tests
dc.subject.meshImmunoglobulin E
dc.subject.meshPenicillins
dc.subject.meshDrug Hypersensitivity
dc.subject.meshSodium Tetradecyl Sulfate
dc.subject.meshAnti-Bacterial Agents
dc.titleResensitization in suspected penicillin allergy.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number78
dspace.entity.typePublication

Files